Page 26 - Research Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lindbrook Capital LLC boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 97.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 132 shares of the medical research company’s stock after buying an additional 65 shares during the period. Lindbrook Capital LLC’s holdings in Charles River Laboratories International were worth […]

Curi Wealth Management LLC cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.9% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 51,308 shares of the medical research company’s stock after selling 3,190 shares during the quarter. Charles River Laboratories International accounts for 1.5% of Curi Wealth […]

Baillie Gifford & Co. lessened its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 0.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 85,096 shares of the medical research company’s stock after selling 394 shares during the […]

Charles River Laboratories International (NYSE:CRL – Free Report) had its price objective cut by Evercore ISI from $235.00 to $225.00 in a report issued on Wednesday, FlyOnTheWall reports. Other equities analysts also recently issued reports about the stock. Guggenheim lowered their price objective on shares of Charles River Laboratories International from $255.00 to $225.00 and […]

Mountain Pacific Investment Advisers Inc. ID lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 13.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 124,360 shares of the medical research company’s stock […]